APA

McClung M. R., Zanchetta J. R., Racewicz A., Roux C., Benhamou C., Man Z., Eusebio R. A., Beary J. F., Burgio D. E., Matzkin E., Boonen S. & Delmas P. (20130610). Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

Chicago

McClung M R, Zanchetta J R, Racewicz A, Roux C, Benhamou C-L, Man Z, Eusebio R A, Beary J F, Burgio D E, Matzkin E, Boonen S and Delmas P. 20130610. Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

Harvard

McClung M. R., Zanchetta J. R., Racewicz A., Roux C., Benhamou C., Man Z., Eusebio R. A., Beary J. F., Burgio D. E., Matzkin E., Boonen S. and Delmas P. (20130610). Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

MLA

McClung M R, Zanchetta J R, Racewicz A, Roux C, Benhamou C-L, Man Z, Eusebio R A, Beary J F, Burgio D E, Matzkin E, Boonen S and Delmas P. Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data. : Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 20130610.